Das US Center for Disease Control and Prevention (CDC) hat gewarnt, dass h\u00e4ufig verwendete Ger\u00e4te zum Erhitzen und K\u00fchlen von Blut w\u00e4hrend Operationen am offenen Herzen mit einem gef\u00e4hrlichen Bakterium, Mycobacterium Chimaera, kontaminiert sein k\u00f6nnten. Dieses Bakterium ist in der Lage, \u00fcber Wochen oder Monate heimlich einen klebrigen Film um ein Herz herum zu bilden. Dieser klebrige Film kann mehrere Komplikationen verursachen, einschlie\u00dflich des Todes. In Zusammenarbeit mit der CDC und der US-amerikanischen Food and Drug Administration (FD) haben Einrichtungen f\u00fcr Operationen am offenen Herzen ihre Patienten mit Operationen am offenen Herzen kontaktiert, um sie darauf hinzuweisen, dass sie dieser bakteriellen Infektion ausgesetzt sein k\u00f6nnten.<\/p>\n
The St\u00f6ckert 3T heater-cooler, manufactured in Germany by LivaNova PLC, was found to be contaminated by the Mycobacterium chimaera bacteria. Despite thorough device cleanings, more cases of infections began popping up across the United States. This prompted officials to suspect that the contamination occurred in the factory during production.<\/p>\n
Anyone who has had open heart surgery since 2011 should consult a medical professional if you are experiencing \u00a0any sign of infection such as fever, fatigue, unintended sweat loss or weight loss. Since the complications associated with M.chimaera could be a long time, it is of the utmost importance to see a doctor if you feel out of the ordinary during recovery. We also encourage you to speak with one of our experienced attorneys to discuss your individual circumstances. The consultation is confidential and free.<\/p>","protected":false},"excerpt":{"rendered":"
The U.S. Center for Disease Control and Prevention (CDC) has issued warning \u00a0that commonly used device for heating and cooling blood during open-heart surgery may be contaminated with a dangerous…<\/p>","protected":false},"featured_media":0,"menu_order":189,"template":"","practiceareas_category":[743],"class_list":["post-5791","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas\/5791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas\/5791\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/media?parent=5791"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas_category?post=5791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}